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Introduction
Hydrocephalus is one of the most prevalent disorders 
relating to the cerebrospinal fluid (CSF) motion.1 
Hydrocephalus referred to the problem in production, 
fellow, and absorption of CSF, which leads to an increase 
in CSF within the intracranial compartment.2 It has a 
considerable incidence in the Eastern Mediterranean 
Region of WHO. It has estimated that annually around 
38 000 new cases of hydrocephalus diagnosed in this 
region.1
In recent decades several approaches, including 
ventricular shunts and endoscopic third ventriculostomy 
(ETV), have been introduced as a treatment of 
hydrocephalus.3 Although ventricular shunts are known 
as the standard treatment of hydrocephalus, this approach 
is not free from complications. Moreover, the failure rate 
of the ventricular shunt is slightly high, and it reported 
between 30%-80% in previous studies. 4,5
On the other hand, endoscopic techniques have been 
developed in recent decades and provided desirables 
outcomes. Comparing to ventricular shunts, the risk of 
infection and malfunction is lower in ETV. Also, ETV is 
more accessible in developing countries and imposes less 
cost to both patients and the health system. Many studies 
have fully supported.6,7 Although the effectiveness of 
ETV in adult and older children, the usefulness of using 
ETV in infants, which mostly suffer from secondary 
hydrocephalus due to infection and myelomeningocele, is 
still challenging. As the number of younger than 6-month 
hydrocephalus patients considered in our setting, we 
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Abstract
Background:The study carried out to assess long-term outcomes of endoscopic third ventriculostomy 
(ETV) on less than two years of hydrocephalous children and to determine prognostic factors of ETV 
success in this population.
Methods: our study was a retrospective cohort study carried out on 40 hydrocephalus children who 
underwent ETV surgery. Clinical data retrieved from patient’s medical records, and we did an active 
follow-up.  We used Kaplan-Meier and life-table approaches to assess 6 months success rate of 
ETV. We also used multiple cox regression to determine prognostic factors associated with success. 
Moreover, the ROC curve analysis was used to assess how ETV success score (ETVSS) can predict 
the possibility of ETV failure.
Results: The mean age of patients at surgery time was 7.8 ( ± 7.8) months, and 60% were male. The 
mean failure time of ETV was 4.5 months, and the most common etiology was aqueduct (27.0%). 
According to our finding age at surgery time (hazard ratio [HR] = 2.2, 95% CI = 1.1, 3.4) and birth age 
(HR = 4.4, 95% CI 1.1, 17.2) were the main factors associated with ETV failure. We also observed, 
statistically lower HR for patients with aqueduct etiology (HR = 0.1, 95% CI = 0.01, 0.9). Moreover, 
the area under the ROC curve was estimated at 76.1, illustrating partial validity to predict ETV failure 
in the study population.
Conclusion: According to our findings, ETV could suggest treating Hydrocephaly in young kids with 
particular attention on over 6-month patients and those who were mature at birth. However, more 
studies are required to confirm our findings.
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aimed to compare the efficacy of ETV between infants 
and older children. In the current study, we assessed 
prognosis and long-term complications of ETV in less 
than two-year children.   
Materials and Methods 
The current study was a retrospective study carried out 
on 40 less than 2 years of hydrocephalus patients who 
were referred to the Mofid and Imam-Hossein hospitals 
in Tehran from 2013 to 2018. Clinical information of 
study participants, including date of ETV surgery, age at 
the time of ETV surgery, sex, and cause of hydrocephalus 
extracted from medical records. We also estimated ETV 
success score (ETVSS) for each participant through the 
information of medical records and patients visits by 
a neurosurgery resident. We followed patients actively 
through telephone or face to face interviews, and 
during the interview, they asked about the increase or 
improvement of Intra Cranial pressure raising symptoms 
(ICP), presence of neurologic disorders, growth status of 
the patient, re-ETV, or need to ventricular shunt, vital 
status, and cause of death. Death after surgery due to an 
increase of ICP and need to re-ETV or shunt placement 
along with worsening of clinical signs defined as the 
failure of ETV. The decision for re-operation made when 
the increase in intracranial pressure besides enlargement 
of ventricles observed in post-operative images compare 
to pre-operative ones.
Statistical Analysis 
We reported mean and standard deviation to report 
distribution of continuous variables across comparing 
groups. We also used the proportion and 95% CI for 
dichotomous variables. Kaplan-Meier and life table 
approaches were applied to report the survival time 
of ETV. We also used a multiple Cox regression to 
investigate the association between failure of ETV and the 
investigated variables.
Furthermore, we draw a ROC curve to determine the 
best cut-off point for ETVSS in order to predict the success 
of ETV, and for the estimated cut-point sensitivity and 
specificity was calculated. The cut-point was estimated 
based on the highest sensitivity and specificity. All 
statistical analysis was carried out by SPSS version 22.0.
Results 
The mean age ( ± SD) of study participants was 7.8 ( ± 7.8) 
month, and 60.0% of whom were men. Aqueduct (25.0%) 
was the most prevalent etiology of hydrocephalus, while 
myelomeningocele had the lowest proportion (10.0%). 
22.5% of the patient was born pre-term, and mean of head 
circumstances at birth and ETV time were 34.1 and 43.6, 
respectively. Finally, the mean of pre-operative ETVSS as 
estimated at 57.6 ( ± 12.4) (Table 1). 
The success rate of ETV was reported 70.3% (95% CI, 
49.4, 73.9) for less than the 6-month group, while it was 
92.3% (95% CI, 74.1, 98.8) and the observed difference 
was statistically significant (P = 0.047) (Figure 1). We also 
observed a partially higher success rate in females (81.2%) 
comparing to male (75.0%). However, no statistical 
difference observed (P = 0.790). Success rate of ETV 6 
month after surgery in pre-term infants was 60.0% (95% 
CI, 25.2, 82.7) which was considerably lower than term 
ones (success rate = 86,6%, 95% CI, 68.2, 94.7) (P = 0.028) 
(Figure 2). We also observed the highest 6-month survival 
of ETV in patients with aqueduct etiology (90.1%, 95% 
CI, 50.8, 98.6), and myelomeningocele etiology had the 
lowest success rate (success rate = 50.0%, 95% CI, 5.7, 
Table 1. Study Participants Characteristics





Under 6 months 27 67.5
6-24 months 13 32.5
Etiology
Idiopathic 8 20.0
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Table 2. Success rate of ETV Across Age, Sex, Etiology and Birth Age
Variable Subgroups Success Rate 95% CI P Value
Gender
Male 75.0 52.6, 87.9
Female 81.2 52.4, 93.5 0.790
Age group
Under 6 months 70.3 49.4, 73.9
6-24 months 92.3 74.1, 98.8 0.047
Etiology
Idiopathic 87.5% 38.7, 98.1
Dandy walker 60.0 25.2, 82.7
Aqueduct 90.1 50.8, 98.6
Myelomeningocele 50.0 5.7, 84.4
Meningitis 71.4 13.2, 97.8 0.109
Birth age
Pre-term 60.0 25.2, 82.7
Term 86.6 68.2, 94.7 0.028
84.4) (P = 0.109) (Table 2). 
ETVSS the best cut-point estimated according to 
highest sensitivity and specificity at 55 and the estimated 
cut-point sensitivity and specificity of ETVSS for the 
success of ETV was 62.0% and 63.6%, respectively. Area 
under curve (AUC) was also 76.1 (95% CI, 61.4, 90.8) 
(Figure 3 ).
We also assessed the adjusted effect of the investigated 
variables through multiple cox regression. The hazard 
ratio for pre-term born estimated at 4.4 (95% CI, 1.1, 
17.2), which was statistically significant (P = 0.029). 
We also observed a statistically significant association 
between age at ETV and the success rate of ETV (hazard 
ratio [HR] = 2.2, 95% CI = 1.1, 3.4). Moreover, over 55 
ETVSS scores increased the hazard of ETV failure by 
2.1. However it was not statistically significant (95% CI, 
0.8, 3.2) (P = 0.067). The hazard ratio of ETV failure for 
Aqueduct etiology was significantly lower than patients 
with Dandy-Walker syndrome etiology (HR = 0.1, 95% 
CI, 0.01, 0.9) (Table 3). 
Discussion 
In this study, we aimed to compare the efficacy of ETV 
on over and under 6-month children who diagnosed 
with hydrocephalus at Imam Hossein and Mofid hospital 
from 2013 to 2018. The success rate of ETV for less than 
6 months and over 6-month children was 70.3 and 92.3, 
respectively. We also demonstrated a significantly lower 
success rate for those patients who were born pre-term. 
Etiology and ETVSS were other main prognostic factors 
for ETV success.  
The overall success rate of ETV was 80.0%, and it 
provided significantly better outcomes in older children. 
Beuriat et al have reported a 70.0% success rate, which 
Figure 1. Success Rate of ETV by Age Groups  Figure 2. success Rate of ETV by Birth Age Group (Term/Pre-
term) 
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is inside of our findings.7 Several other studies reported 
higher than 70% success rate for ETV in children who 
support our study results.8-11
 Age at ETV has previously shown as a prognostic 
factor of ETV success in several studies. Most studies 
reported a reduced success rate in younger children 
and in the recent study in support of previous findings 
we reported a significantly higher success rate for older 
patients.12-15 Several pathological mechanisms have 
already introduced for the lower success rate of ETV in 
younger patients.16,17 Poor absorption of CSF is one the 
most critical factor which seems is responsible for the 
failure of ETV. However, Wagner et al suggested that the 
formation of new arachnoid may play a vital role in this 
regard, even more, critical than poor absorption of CSF. 
It has argued that a higher tendency to new arachnoid 
membranes in younger patients may explain the higher 
ETV failure among them.17 
Furthermore, we found that patients with preterm birth 
had a lower success rate comparing those patients who 
were mature at birth time. As it mentioned absorption of 
CSF is one the most critical factor in terms of ETV success 
rate, and it seems lower absorption capacity in premature 
infants due to less development of the central nervous 
system is the main reason to justify this difference. 
The most favorable outcome was observed in patients 
with aqueduct stenosis etiology, while the lowest 
success rate observed in Dandy-Walker syndrome and 
myelomeningocele etiologies. It has already shown that 
the overall success rate in aqueduct stenosis is pretty 
higher; however, other studies reported no difference 
regarding etiology.11-18 
We also used ETVSS as a predictor of the ETV success 
rate, and it has illustrated that it could consider as a 
moderate predictor for prognosis of ETV surgery in 
children. The best cut-off point for ETVSS estimated at 
55.0, according to the highest sensitivity and specificity. 
We observed inconsistency in our findings compares to 
the previous studies. García et al8 reported high validity 
for ETVSS to predict ETV failure among older than 1 
year children, eight while Kulkarni et al showed that 
ETVSS could not be used as a valid measure for ETVSS 
prognosis.19 There are some other studies, which reported 
low sensitivity and specificity for ETVSS. As these studies 
Table 3. Association Between ETVSS and ETV Success Rate Adjusted for Age, Sex, Birth Age and Etiology
Variable Subgroups Hazard Ratio 95% CI P Value
Gender
Male 1
Female 1.3 0.3, 5.1 0.618
Age group
6- 24 months 1
Under 6 months 2.2 1.1, 3.4 0.048
Etiology
Dandy walker 1
Idiopathic 0.2 0.02, 1.7 0.149
Aqueduct 0.1 0.01, 0.9 0.046
Meningitis 0.5 0.1, 2.8 0.486
Myelomeningocele 1.5 0.2, 8.3 0.600
Birth age
Term 1
Pre-term 4.4 1.1, 17.2 0.029
ETVSS
Over 55 1
Under 55 2.1 0.8, 3.2 0.067
Figure 3. ETVSS ROC Curve to Estimate the Best Cut-Point 
According to Highest Sensitivity and Specificity
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have carried out on patients in different age groups, it 
seems to age at ETV time is also an essential factor for the 
validity of ETVSS, and among older children, ETVSS is 
the more valid index to predict success rate.   
The current study carried out on all children who 
were admitted with hydrocephalus at 2 distinctive 
neurosurgery centers in Tehran for 5 years. This is the first 
research in which we compared the long-term outcome of 
ETV surgery in Iranian children. The same surgeon has 
operated all patients and in the same condition to remove 
the effect of surgeon proficiency and difference in provided 
care. However, there are some limitations which could 
be regarded to generalize our findings. The low sample 
size was the main limitation of our study that reduces the 
generalizability of our findings. Moreover, we followed 
the patient’s complications and outcomes retrospectively 
through medical records, and this approach could affect 
data quality.
In conclusion, ETV provides more favorable outcomes 
in older children, and those who were mature at birth 
and applying this surgery for younger children suffering 
from hydrocephalus must use with some considerations. 
However, it seems a multi-center and prospective study 
with a larger sample size required for more deterministic 
decision-making.
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